166 related articles for article (PubMed ID: 33057928)
1.
Kirchner J; Hatzoglou V; Buthorn JB; Bossert D; Sigler AM; Reiner AS; Ulaner GA; Diamond EL
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1154-1165. PubMed ID: 33057928
[TBL] [Abstract][Full Text] [Related]
2. The role of 2-[
Pudis M; Palomar-Muñoz A; Solanich-Moreno X; Robles-Barba JJ; Rocamora-Blanch G; Rodríguez-Bel L; Narváez JA; Cortés-Romera M
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(1):14-22. PubMed ID: 37804884
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
4.
Young JR; Johnson GB; Murphy RC; Go RS; Broski SM
J Nucl Med; 2018 May; 59(5):774-779. PubMed ID: 29097410
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Resolution of Lytic Lesions in Erdheim-Chester Disease on 18F-FDG PET/CT.
Yadav D; Seth R; Shamim SA; Kumar R
Clin Nucl Med; 2020 Dec; 45(12):e514-e515. PubMed ID: 32604106
[TBL] [Abstract][Full Text] [Related]
6. Response Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing
Vogsen M; Harbo F; Jakobsen NM; Nissen HJ; Dahlsgaard-Wallenius SE; Gerke O; Jensen JD; Asmussen JT; Jylling AMB; Braad PE; Vach W; Ewertz M; Hildebrandt MG
J Nucl Med; 2023 Mar; 64(3):355-361. PubMed ID: 36207136
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim-Chester disease].
Girszyn N; Arnaud L; Villain D; Kahn JE; Piette AM; Bletry O
Rev Med Interne; 2007 Nov; 28(11):770-4. PubMed ID: 17629593
[TBL] [Abstract][Full Text] [Related]
8. Pineal gland involvement in Erdheim-Chester disease detected on (18)F-FDG PET-CT imaging: a case report and review of literature.
Mukherjee A; Dhull VS; Karunanithi S; Sharma P; Durgapal P; Kumar R
Clin Imaging; 2014; 38(3):367-71. PubMed ID: 24461468
[TBL] [Abstract][Full Text] [Related]
9. Erdheim-Chester Disease Occult on Radiographs and CT but Visible on MRI and PET.
Kim M; Rowe SP; Mehta TI
Am J Case Rep; 2024 Mar; 25():e941169. PubMed ID: 38553814
[TBL] [Abstract][Full Text] [Related]
10. Skeletal involvement in Erdheim-Chester disease: Multimodality imaging features and association with the BRAF
Nikpanah M; Dehghani Firouzabadi F; Farhadi F; Mirmomen SM; Ahlman MA; Huda F; Millo C; Saboury B; Paschall AK; Gahl WA; Estrada-Veras JI; Turkbey E; Jones EC; O'Brien K; Malayeri AA
Clin Imaging; 2024 Feb; 106():110067. PubMed ID: 38128404
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of nuclear medicine in Erdheim-Chester disease: A Lille experience].
Adens A; Landy P; Terriou L; Baillet C; Beron A; Lambert M; Launay D; Huglo D
Rev Med Interne; 2017 Apr; 38(4):235-242. PubMed ID: 28268124
[TBL] [Abstract][Full Text] [Related]
12. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
Diamond EL; Subbiah V; Lockhart AC; Blay JY; Puzanov I; Chau I; Raje NS; Wolf J; Erinjeri JP; Torrisi J; Lacouture M; Elez E; Martínez-Valle F; Durham B; Arcila ME; Ulaner G; Abdel-Wahab O; Pitcher B; Makrutzki M; Riehl T; Baselga J; Hyman DM
JAMA Oncol; 2018 Mar; 4(3):384-388. PubMed ID: 29188284
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease.
Arnaud L; Malek Z; Archambaud F; Kas A; Toledano D; Drier A; Zeitoun D; Cluzel P; Grenier PA; Chiras J; Piette JC; Amoura Z; Haroche J
Arthritis Rheum; 2009 Oct; 60(10):3128-38. PubMed ID: 19790052
[TBL] [Abstract][Full Text] [Related]
14. Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease.
Cao XX; Niu N; Sun J; Cai H; Wang FD; Wang YN; Duan MH; Zhou DB; Li J
Orphanet J Rare Dis; 2019 Jan; 14(1):11. PubMed ID: 30630516
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease.
Pereira Neto CC; Roman C; Johnson M; Jagasia M; Martin WH; Delbeke D
Mol Imaging Biol; 2004; 6(1):63-7. PubMed ID: 15018830
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
[TBL] [Abstract][Full Text] [Related]
17. F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease.
Ambrosini V; Savelli F; Merli E; Zompatori M; Nanni C; Allegri V; Fanti S
Clin Nucl Med; 2012 Feb; 37(2):196-7. PubMed ID: 22228352
[TBL] [Abstract][Full Text] [Related]
18. A Unique Case of Erdheim-Chester Disease With Cervical and Lumbosacral Nerve Involvement: FDG PET/CT Finding.
Niu N; Cao X; Cui R
Clin Nucl Med; 2016 Nov; 41(11):881-883. PubMed ID: 27607166
[TBL] [Abstract][Full Text] [Related]
19. FDG PET images in a patient with Erdheim-Chester disease.
Sioka C; Estrada-Veras J; Maric I; Gahl WA; Chen CC
Clin Nucl Med; 2014 Feb; 39(2):170-7. PubMed ID: 23640213
[TBL] [Abstract][Full Text] [Related]
20. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.
Wahl RL; Jacene H; Kasamon Y; Lodge MA
J Nucl Med; 2009 May; 50 Suppl 1(Suppl 1):122S-50S. PubMed ID: 19403881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
